GXFC3 (Combivir 150 mg / 300 mg)
Generic Name: lamivudine/zidovudine
Pill with imprint GXFC3 is White, Elliptical / Oval and has been identified as Combivir 150 mg / 300 mg. It is supplied by GlaxoSmithKline.
Combivir is used in the treatment of hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Combivir 150 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GXFC3
Combivir
- Generic Name
- lamivudine/zidovudine
- Imprint
- GXFC3
- Strength
- 150 mg / 300 mg
- Color
- White
- Size
- 17.00 mm
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Antiviral combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- GlaxoSmithKline
- National Drug Code (NDC)
- 00173-0595
- Inactive Ingredients
-
silicon dioxide colloidal,
hypromelloses,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol,
polysorbate 80,
sodium starch glycolate type A potato,
titanium dioxide
Note: Inactive ingredients may vary.
Related Images for "GXFC3"
More about Combivir (lamivudine / zidovudine)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 4 Reviews
- Generic Availability
- Drug class: antiviral combinations
- FDA Alerts (2)
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.